- Surgeon

More than 85 percent of surgeons—both breast specialists and general surgeons—continue to follow breast cancer screening recommendations more closely aligned with those of the American Cancer Society, the American College of Radiology (ACR) and the Society of Breast Imaging, rather than those issued by the U.S. Preventive Services Task Force (USPSTF), according to results presented April 21 at the ARRS 2015 Annual Meeting in Toronto.

 - Reviewing Results - Workflow Throughput

A majority of radiology patients prefer to hear their results from the ordering provider rather than a radiologist, while most want to the option to review the images and reports from their imaging tests, according to study results published online April 16 by the Journal of the American College of Radiology.

 - PET/MR, colorectal cancer, molecular imaging

With the dramatic increase in capabilities and importance of individualized cancer therapies targeting specific tumors according to molecular makeup, it would seem like a no-brainer to incorporate a wide-range of imaging biomarkers into clinical trials and, eventually, clinical practice. So what's the holdup?

 - Checklist

A meta-analysis of studies focused on the implementation of clinical decision support (CDS) for imaging found moderate evidence that integrating such tools with the EHR can improve appropriate imaging use and yield a small decrease in test ordering, but more research must be done, particularly on possible harms.

 - Radiologist Working Late

Last week, the Centers for Medicare and Medicaid Services (CMS) released a new rule proposal meant to “align Stage 1 and Stage 2 objectives and measures with the long-term proposals for Stage 3, to build progress toward program milestones, to reduce complexity, and to simplify providers’ reporting.” But what does it all mean for the imaging sector?